CD274 and renal cell carcinoma: Of the 177 full-texts of clinical studies involving the use of anti PD-1/PD-L1 agent in RCC that were evaluated, 6 full text articles [15,16,17,18,19,20] reporting data from RCTs were finally included in the quantitative meta-analysis.